Melanotan II · research summary

Zebrafish Bioassay for Screening Therapeutic Candidates Based on Melanotrophic Activity.

International journal of molecular sciences · 2021. Summary drawn from the study's full text. Each statement is followed by the exact sentence it comes from. This is a research summary, not medical advice.

Study type

In vitro bioassay using zebrafish larvae to measure melanophore dispersion in response to alpha-MSH analogues
“In this study, we used the zebrafish animal model to establish a bioassay by which physiological efficacy differential of alpha-melanocyte-stimulating hormone (α-MSH) analogues could be measured by melanosome dispersion in zebrafish larvae.”

Subjects

Wild-type zebrafish larvae (48–60 hours post fertilization)
“Thus, 48 h post fertilization (hpf) to 60 hpf zebrafish larvae were selected for the assay experiment.”

Sample size

Up to five larvae per well for the dish protocol and 3–5 larvae per capillary tube for the restriction array protocol
“Each assay trial was conducted initially with five larval replicates per well; however, in certain cases, some samples either expired or were damaged during the experiment and were excluded from data analysis.”

Duration

The restriction array protocol involved a 70-minute peptide treatment period with imaging at 10-minute intervals
“Melatonin treatment and peptide treatment times were 10 min and 70 min, respectively.”

Reported findings

Synthetic analogue melanotan-II (MT-II) induced greater melanophore dispersion than human alpha-MSH
“Using the restriction array protocol, MT-II was found to effect greater melanosome dispersion than human α-MSH, demonstrating the sensitivity of the melanophore assay to detect and differentiate low potency compounds as well as to accurately measure compounds of greater pharmacological efficacy, such as MT-II.”
Naturally occurring fish alpha-MSH variants produced differential effects on melanophore dispersion, with none exceeding the dispersion caused by the human form
“From an initially aggregated state, each of the four unique fish peptides produced different degrees of melanosome dispersion (zebrafish: 1051.04 μm2, carp: 781.03 μm2, cavefish: 472.68 μm2, and salmon: 1721.08 μm2), although none exceeded dispersion of the human form (1898.20 μm2) (Figure 4b).”
The melanophore assay demonstrated sensitivity to subtle changes in amino acid sequence and compound stability over time
“Our aim was to develop an assay method that was sensitive to subtle changes in the amino acid sequence of test peptides.”

Limitations stated by the authors

The molecular reasons for differential discrimination in the assay, such as half-life or solubility of various peptides, require further investigation
“However, the differential outcomes of α-MSH variants affirmed our original expectation for the melanophore assay to differentially express sequence variants of α-MSH-based peptides, while the molecular reason of this discrimination in the assay needs further investigation—e.g., regarding the half-life or solubility of various peptides.”

Source: PubMed 34502223 · DOI 10.3390/ijms22179313 · all study summaries

Study type

In vitro bioassay using zebrafish larvae to measure melanophore dispersion in response to alpha-MSH analogues

“In this study, we used the zebrafish animal model to establish a bioassay by which physiological efficacy differential of alpha-melanocyte-stimulating hormone (α-MSH) analogues could be measured by melanosome dispersion in zebrafish larvae.”

Sample size

Up to five larvae per well for the dish protocol and 3–5 larvae per capillary tube for the restriction array protocol

“Each assay trial was conducted initially with five larval replicates per well; however, in certain cases, some samples either expired or were damaged during the experiment and were excluded from data analysis.”

Reported findings

Synthetic analogue melanotan-II (MT-II) induced greater melanophore dispersion than human alpha-MSH

“Using the restriction array protocol, MT-II was found to effect greater melanosome dispersion than human α-MSH, demonstrating the sensitivity of the melanophore assay to detect and differentiate low potency compounds as well as to accurately measure compounds of greater pharmacological efficacy, such as MT-II.”

Naturally occurring fish alpha-MSH variants produced differential effects on melanophore dispersion, with none exceeding the dispersion caused by the human form

“From an initially aggregated state, each of the four unique fish peptides produced different degrees of melanosome dispersion (zebrafish: 1051.04 μm2, carp: 781.03 μm2, cavefish: 472.68 μm2, and salmon: 1721.08 μm2), although none exceeded dispersion of the human form (1898.20 μm2) (Figure 4b).”

The melanophore assay demonstrated sensitivity to subtle changes in amino acid sequence and compound stability over time

“Our aim was to develop an assay method that was sensitive to subtle changes in the amino acid sequence of test peptides.”

Limitations stated by the authors

The molecular reasons for differential discrimination in the assay, such as half-life or solubility of various peptides, require further investigation

“However, the differential outcomes of α-MSH variants affirmed our original expectation for the melanophore assay to differentially express sequence variants of α-MSH-based peptides, while the molecular reason of this discrimination in the assay needs further investigation—e.g., regarding the half-life or solubility of various peptides.”